Mukaltin - instructions for use, dose, side effects, contraindications

Similar drugsTo uncover

Dosage form: & nbsppills

Composition:

For one tablet:

active substance: althaea officinalis Herbs extract (mucaltin) - 50 mg;

Excipients: sodium hydrocarbonate - 86.5 mg, tartaric acid - 158.9 mg, povidone (polyvinylpyrrolidone low molecular weight medical) - 1.6 mg, calcium stearate - 3 mg.

Description:

Tablets from light gray to brownish-gray color with impregnations of a lighter and darker color, with a specific odor, flat-cylindrical, with a risk and a facet.

Pharmacotherapeutic group:Expectorant of plant origin

ATX: & nbsp

Expectorants

Pharmacodynamics:

Mukaltin is a mixture of polysaccharides of althea medicinal herb, possesses expectorant properties. Thanks to reflex stimulation, it intensifies the activity of the ciliated epithelium and the peristalsis of respiratory bronchioles in combination with increased secretion of the bronchial glands.

Indications:

Acute and chronic respiratory diseasespathways accompanied by coughing and formation of difficult sputum increased viscosity (including tracheobronhit, obstructive bronchitis, bronchiectasis, pneumonia) - as part of complex therapy.

Contraindications:

Hypersensitivity to the components of the drug, peptic ulcer of the stomach and duodenum, children under 12 years.

Pregnancy and lactation:

The use of the drug during pregnancy and during breastfeeding is possible on the advice of a doctor.

Dosing and Administration:

Adults and children from 12 years inside 1-2 tablets 2-3 times a day before meals. The average course of treatment is 7-14 days. Children can dissolve the tablet in 1/3 cup of warm water.

Side effects:

Allergic reactions, dyspeptic phenomenon.

Overdose:

To date, cases of overdose have not been reported.

Interaction:

Mucaltin can be prescribed concomitantly with other drugs used in the treatment of bronchopulmonary diseases.

Mucaltin should not be used concomitantly with drugs containing codeine and other antitussive medicines, as this makes it difficult to cough up thinned phlegm.

Effect on the ability to drive transp. cf. and fur:The drug does not affect the ability to drive vehicles, as well as employment in other potentially hazardous activities that require increased attention and speed of mental and motor reactions.

Form release / dosage:

Tablets of 50 mg.

Packaging:

For 10 tablets in a contour non-jawed package.

3, 5 or 10 contour non-jawed packages together with instructions for use in the pack.

It is allowed to place contour non-cellular packages with an equal number of instructions for use directly in the group package.

Storage conditions:

Store at a temperature not exceeding 15 ° C and relative humidity not more than 60%.

Keep out of the reach of children.

Shelf life:

2 years. Do not use after the expiration date.

Terms of leave from pharmacies:Without recipe

Registration number:LS-001833

Date of registration:09.07.2010

Expiration Date:Unlimited

The owner of the registration certificate:PHARMSTANDART-FORESTRY, OJSC PHARMSTANDART-FORESTRY, OJSC Russia

Manufacturer: & nbsp

PHARMSTANDART-FORESTRY, OJSC Russia

Information update date: & nbsp31.05.2018

Illustrated instructions

Instructions

Mukaltin (Mucaltin)